Comments
Pursuant to the provisions of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, we are hereby enclosing Audited Financial Results for the quarter as well as year ended 31st March, 2019 duly approved by the Board of Directors of the Company at its meeting held on today i.e. Thursday, 30th May, 2019 at the registered office of the Company together with Auditors Report thereon, Statements of Assets and Liabilities and declaration by the Managing Director of the Company pursuant to second proviso of Regulation 33(3) (d) of SEBI Listing Regulations, 2015. You are requested to take on record the above said financial results for your reference and record.
Pdf Link: Biofil Chemicals & Pharmaceuticals Ltd. - Results For The Financial Year Ended On 31St March 2019.
Source : BSE - www.bseindia.com
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.